Eric Johansen

Dr. Eric Johansen


Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1985 in Cell
Verified
Journal Article
Closed access
TFTurlough M. Finan
Turlough M. Finan
AHAnn M. Hirsch
Ann M. Hirsch
JLJohn A. Leigh
John A. Leigh
EJEric Johansen
Eric Johansen
GKGretchen A. Kuldau
Gretchen A. Kuldau
ESEthan R. Signer
Ethan R. Signer

28 March 2014 in Microorganisms
Verified
Journal Article
Open access
PDF file
MJMikkel Jungersen
Mikkel Jungersen
AWAnette Wind
Anette Wind
EJEric Johansen
Eric Johansen
JCJeffrey E. Christensen
Jeffrey E. Christensen
BSBirgitte Stuer-Lauridsen
Birgitte Stuer-Lauridsen
DEDorte Eskesen
Dorte Eskesen
This review presents selected data on the probiotic strain Bifidobacterium animalis subsp. lactis BB-12® (BB-12®), which is the world’s most documented probiotic Bifidobacterium. It is described in more than 300 scientific publications out of which more than 130 are publications of human clinical studies. The complete genome sequence of BB-12® has been determined and published. BB-12® originates from Chr. Hansen’s collection of dairy cultures and has high stability in foods and as freeze dried powders. Strain characteristics and mechanisms of BB-12® have been established through extensive in vitro testing. BB-12® exhibits excellent gastric acid and bile tolerance; it contains bile salt hydrolase, and has strong mucus adherence properties, all valuable probiotic characteristics. Pathogen inhibition, barrier function enhancement, and immune interactions are mechanisms that all have been demonstrated for BB-12®. BB-12® has proven its beneficial health effect in numerous clinical studies within gastrointestinal health and immune function. Clinical studies have demonstrated survival of BB-12® through the gastrointestinal tract and BB-12® has been shown to support a healthy gastrointestinal microbiota. Furthermore, BB-12® has been shown to improve bowel function, to have a protective effect against diarrhea, and to reduce side effects of antibiotic treatment, such as antibiotic-associated diarrhea. In terms of immune function, clinical studies have shown that BB-12® increases the body’s resistance to common respiratory infections as well as reduces the incidence of acute respiratory tract infections.

1 April 2006 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SKStefan R. Kappeler
Stefan R. Kappeler
HBHans (J.) M. van Den Brink
Hans (J.) M. van Den Brink
HRHenrik Rahbek-Nielsen
Henrik Rahbek-Nielsen
ZFZakaria Farah
Zakaria Farah
ZPZdenko Puhan
Zdenko Puhan
EJEric Johansen
Eric Johansen

1 November 2007 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
BSBorja Sanchez
Borja Sanchez
MCMarie-Christine Champomier-Vergès
Marie-Christine Champomier-Vergès
BSBirgitte Stuer-Lauridsen
Birgitte Stuer-Lauridsen
Patricia Ruas-MadiedoPatricia Ruas-Madiedo
Patricia Ruas-Madiedo
PAPatricia Anglade
Patricia Anglade
AMAbelardo Margolles
Abelardo Margolles
Bile salts are natural detergents that facilitate the digestion and absorption of the hydrophobic components of the diet. However, their amphiphilic nature makes them very inhibitory for bacteria and strongly influences bacterial survival in the gastrointestinal tract. Adaptation to and tolerance of bile stress is therefore crucial for the persistence of bacteria in the human colonic niche. Bifidobacterium animalis subsp. lactis , a probiotic bacterium with documented health benefits, is applied largely in fermented dairy products. In this study, the effect of bile salts on proteomes of B. animalis subsp. lactis IPLA 4549 and its bile-resistant derivative B. animalis subsp. lactis 4549dOx was analyzed, leading to the identification of proteins which may represent the targets of bile salt response and adaptation in B. animalis subsp. lactis . The comparison of the wild-type and the bile-resistant strain responses allowed us to hypothesize about the resistance mechanisms acquired by the derivative resistant strain and about the bile salt response in B. animalis subsp. lactis . In addition, significant differences in the levels of metabolic end products of the bifid shunt and in the redox status of the cells were also detected, which correlate with some differences observed between the proteomes. These results indicate that adaptation and response to bile in B. animalis subsp. lactis involve several physiological mechanisms that are jointly dedicated to reduce the deleterious impact of bile on the cell's physiology.

1 January 2014 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
PDPatrick Mf Derkx
Patrick Mf Derkx
TJThomas Janzen
Thomas Janzen
KSKim I Sørensen
Kim I Sørensen
JCJeffrey E Christensen
Jeffrey E Christensen
BSBirgitte Stuer-Lauridsen
Birgitte Stuer-Lauridsen
EJEric Johansen
Eric Johansen
The food industry is constantly striving to develop new products to fulfil the ever changing demands of consumers and the strict requirements of regulatory agencies. For foods based on microbial fermentation, this pushes the boundaries of microbial performance and requires the constant development of new starter cultures with novel properties. Since the use of ingredients in the food industry is tightly regulated and under close scrutiny by consumers, the use of recombinant DNA technology to improve microbial performance is currently not an option. As a result, the focus for improving strains for microbial fermentation is on classical strain improvement methods. Here we review the use of these techniques to improve the functionality of lactic acid bacteria starter cultures for application in industrial-scale food production. Methods will be described for improving the bacteriophage resistance of specific strains, improving their texture forming ability, increasing their tolerance to stress and modulating both the amount and identity of acids produced during fermentation. In addition, approaches to eliminating undesirable properties will be described. Techniques include random mutagenesis, directed evolution and dominant selection schemes.

1 August 2008 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
TRThomas Bovbjerg Rasmussen
Thomas Bovbjerg Rasmussen
MDMorten Danielsen
Morten Danielsen
OVOndrej Valina
Ondrej Valina
CGChristel Garrigues
Christel Garrigues
EJEric Johansen
Eric Johansen
MPMartin Bastian Pedersen
Martin Bastian Pedersen
A DNA microarray platform based on 2,200 genes from publicly available sequences was designed for Streptococcus thermophilus . We determined how single-nucleotide polymorphisms in the 65- to 75-mer oligonucleotide probe sequences affect the hybridization signals. The microarrays were then used for comparative genome hybridization (CGH) of 47 dairy S. thermophilus strains. An analysis of the exopolysaccharide genes in each strain confirmed previous findings that this class of genes is indeed highly variable. A phylogenetic tree based on the CGH data showed similar distances for most strains, indicating frequent recombination or gene transfer within S. thermophilus . By comparing genome sizes estimated from the microarrays and pulsed-field gel electrophoresis, the amount of unknown DNA in each strain was estimated. A core genome comprised of 1,271 genes detected in all 47 strains was identified. Likewise, a set of noncore genes detected in only some strains was identified. The concept of an industrial core genome is proposed. This is comprised of the genes in the core genome plus genes that are necessary in an applied industrial context.